These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 20527510

  • 1. Evaluation of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy.
    Harmanci K, Razi CH, Toyran M, Kanmaz G, Cengizlier MR.
    Asian Pac J Allergy Immunol; 2010 Mar; 28(1):7-13. PubMed ID: 20527510
    [Abstract] [Full Text] [Related]

  • 2. Prevention of new sensitizations by specific immunotherapy in children with rhinitis and/or asthma monosensitized to house dust mite.
    Inal A, Altintas DU, Yilmaz M, Karakoc GB, Kendirli SG, Sertdemir Y.
    J Investig Allergol Clin Immunol; 2007 Mar; 17(2):85-91. PubMed ID: 17460946
    [Abstract] [Full Text] [Related]

  • 3. Development of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy.
    Gulen F, Zeyrek D, Can D, Altinoz S, Koksoy H, Demir E, Tanac R.
    Asian Pac J Allergy Immunol; 2007 Mar; 25(1):7-11. PubMed ID: 17891916
    [Abstract] [Full Text] [Related]

  • 4. Sublingual immunotherapy with house dust extract for house dust-mite allergic rhinitis in children.
    Yonekura S, Okamoto Y, Sakurai D, Horiguchi S, Hanazawa T, Nakano A, Kudou F, Nakamaru Y, Honda K, Hoshioka A, Shimojo N, Kohno Y.
    Allergol Int; 2010 Dec; 59(4):381-8. PubMed ID: 20864799
    [Abstract] [Full Text] [Related]

  • 5. Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study.
    Pajno GB, Barberio G, De Luca F, Morabito L, Parmiani S.
    Clin Exp Allergy; 2001 Sep; 31(9):1392-7. PubMed ID: 11591189
    [Abstract] [Full Text] [Related]

  • 6. Specific immunotherapy is effective in the prevention of new sensitivities.
    Reha CM, Ebru A.
    Allergol Immunopathol (Madr); 2007 Sep; 35(2):44-51. PubMed ID: 17428399
    [Abstract] [Full Text] [Related]

  • 7. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial.
    Aydogan M, Eifan AO, Keles S, Akkoc T, Nursoy MA, Bahceciler NN, Barlan IB.
    Respir Med; 2013 Sep; 107(9):1322-9. PubMed ID: 23886432
    [Abstract] [Full Text] [Related]

  • 8. [Preventive immunotherapy].
    Boquete M, Carballada F, Expósito F, González A.
    Allergol Immunopathol (Madr); 2000 Sep; 28(3):89-93. PubMed ID: 10867376
    [Abstract] [Full Text] [Related]

  • 9. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.
    Pham-Thi N, Scheinmann P, Fadel R, Combebias A, Andre C.
    Pediatr Allergy Immunol; 2007 Feb; 18(1):47-57. PubMed ID: 17295799
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of sublingual tablets of house dust mite allergen extracts in adults with allergic rhinitis.
    Bergmann KC, Demoly P, Worm M, Fokkens WJ, Carrillo T, Tabar AI, Nguyen H, Montagut A, Zeldin RK.
    J Allergy Clin Immunol; 2014 Jun; 133(6):1608-14.e6. PubMed ID: 24388010
    [Abstract] [Full Text] [Related]

  • 11. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children.
    Des Roches A, Paradis L, Menardo JL, Bouges S, Daurés JP, Bousquet J.
    J Allergy Clin Immunol; 1997 Apr; 99(4):450-3. PubMed ID: 9111487
    [Abstract] [Full Text] [Related]

  • 12. Comparison of the long-term efficacy of 3- and 5-year house dust mite allergen immunotherapy.
    Stelmach I, Sobocińska A, Majak P, Smejda K, Jerzyńska J, Stelmach W.
    Ann Allergy Asthma Immunol; 2012 Oct; 109(4):274-8. PubMed ID: 23010234
    [Abstract] [Full Text] [Related]

  • 13. Long-Term Effect of Sublingual and Subcutaneous Immunotherapy in Dust Mite-Allergic Children With Asthma/Rhinitis: A 3-Year Prospective Randomized Controlled Trial.
    Karakoc-Aydiner E, Eifan AO, Baris S, Gunay E, Akturk E, Akkoc T, Bahceciler NN, Barlan IB.
    J Investig Allergol Clin Immunol; 2015 Oct; 25(5):334-42. PubMed ID: 26727762
    [Abstract] [Full Text] [Related]

  • 14. [Clinical efficacy of a standardized specific immunotherapy against house dust mite in 85 asthmatic children].
    Zhang X, Li MR, Wang C, Wang XN, Zhang HL, Lin J, Jin K, Li YC.
    Zhonghua Er Ke Za Zhi; 2010 Jul; 48(7):526-30. PubMed ID: 21055090
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of a glutaraldehyde-modified house dust mite extract in allergic rhinitis.
    Riechelmann H, Schmutzhard J, van der Werf JF, Distler A, Kleinjans HA.
    Am J Rhinol Allergy; 2010 Jul; 24(5):e104-9. PubMed ID: 21244725
    [Abstract] [Full Text] [Related]

  • 16. [Efficacy and safety of sublingual immunotherapy with house dust mite extract in poly allergen sensitized children with allergic rhinitis].
    Zhou L, Wang J, Chen Y, Luo R, Tao J, Nie M, Liu B, Li Y.
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Oct; 26(20):913-6. PubMed ID: 23272490
    [Abstract] [Full Text] [Related]

  • 17. Diagnostic and therapeutic approaches in respiratory allergy are different depending on the profile of aeroallergen sensitisation.
    Domínguez-Ortega J, Quirce S, Delgado J, Dávila I, Martí-Guadaño E, Valero A.
    Allergol Immunopathol (Madr); 2014 Oct; 42(1):11-8. PubMed ID: 23265263
    [Abstract] [Full Text] [Related]

  • 18. Usefulness of specific immunotherapy in patients with severe perennial allergic rhinitis induced by house dust mite: a double-blind, randomized, placebo-controlled trial.
    Varney VA, Tabbah K, Mavroleon G, Frew AJ.
    Clin Exp Allergy; 2003 Aug; 33(8):1076-82. PubMed ID: 12911781
    [Abstract] [Full Text] [Related]

  • 19. Specific IgG4 production during house dust mite immunotherapy among age, gender and allergic disease populations.
    Lai X, Li J, Xiao X, Liu E, Zhang C, Wang H, Gjesing B, Zhong N, Spangfort MD.
    Int Arch Allergy Immunol; 2013 Aug; 160(1):37-46. PubMed ID: 22948109
    [Abstract] [Full Text] [Related]

  • 20. The effect of house dust mite specific immunotherapy on cysteinyl leukotriene production by blood leukocytes in subjects with perennial allergic rhinitis and asthma.
    Saraçlar Y, Sekerel BE, Kalayci O, Adalioğlu G, Tuncer A.
    J Investig Allergol Clin Immunol; 1998 Aug; 8(2):98-104. PubMed ID: 9615303
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.